Subcutaneous Trastuzumab for HER2-positive Breast Cancer – Evidence and Practical Experience in 7 German Centers
Jackisch, C., Müller, V., Dall, P., Neumeister, R., Park-Simon, T.-W., Ruf-Dördelmann, A., Seiler, S., Tesch, H., Ataseven, B.
Published in Geburtshilfe und Frauenheilkunde (01.06.2015)
Published in Geburtshilfe und Frauenheilkunde (01.06.2015)
Get full text
Journal Article
Second interim analysis of HerSCin, a German non-interventional study of subcutaneous trastuzumab for HER2-positive early breast cancer in routine clinical practice
Lüdtke-Heckenkamp, K., Kümmel, S., Ruf-Dördelmann, A., Distelrath, A., Wacker, J., Schmatloch, S., Busch-Liles, S., Schmidt, M.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers
Ortmann, O., Blohmer, J.-U., Sibert, N. T., Brucker, S., Janni, W., Wöckel, A., Scharl, A., Dieng, S., Ferencz, J., Inwald, E. C., Wesselmann, S., Kowalski, C.
Published in Journal of cancer research and clinical oncology (01.03.2023)
Published in Journal of cancer research and clinical oncology (01.03.2023)
Get full text
Journal Article
Klinische Praxis und Ergebnisse der neoadjuvanten Chemotherapie bei frühem Brustkrebs: Analyse der Daten von 94.638 Patienteninnen aus 55 zertifizierten Brustkrebszentren
Ortmann, Olaf, Blohmer, J.-U., Sibert, N. T., Brucker, S., Janni, W., Wöckel, A., Scharl, A., Dieng, S., Ferencz, J., Inwald, E. C., Wesselmann, S., Kowalski, C.
Published in Forum (Heidelberg) (01.12.2022)
Published in Forum (Heidelberg) (01.12.2022)
Get full text
Journal Article